Canada announces first commercial production of lutetium-177

News » Health

 First commercial production of lutetium-177 announced in Canada

Canada announces first commercial production of lutetium-177 for cancer treatment.

in Canada, announced the start of commercial production of lutetium-177.

This is the first of its kind to achieve a commercial power reactor with the added capability of commercial production of short-lived medical isotopes.

Last June Bruce Power announced a plan to produce lutetium-177 (Lu-177) at a commercial nuclear reactor thanks to a new isotope production system (IPS) installed during a scheduled overhaul of the Bruce-7 reactor.

However, this goal was achieved only recently, following the completion of final commissioning and regulatory approval from the Canadian Nuclear Safety Commission for a project to install a new Isotope Production System (IPS) at Bruce Power Unit 7.

Follow us on Telegram

Add a Comment

Your email address will not be published. Required fields are marked *